221 related articles for article (PubMed ID: 15293370)
1. Do pharmacological differences among beta-blockers affect their clinical efficacy in heart failure?
Di Lenarda A; Sabbadini G; Sinagra G
Cardiovasc Drugs Ther; 2004 Mar; 18(2):91-3. PubMed ID: 15293370
[No Abstract] [Full Text] [Related]
2. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
[TBL] [Abstract][Full Text] [Related]
3. In heart failure, all beta-blockers are not necessarily equal.
Tang WH; Militello M; Francis GS
Cleve Clin J Med; 2003 Dec; 70(12):1081-7. PubMed ID: 14686687
[TBL] [Abstract][Full Text] [Related]
4. [For the first time beta blockers are in direct comparison With carvedilol weak hearts beat longer].
MMW Fortschr Med; 2003 Jul; 145(27-28):60. PubMed ID: 14587195
[No Abstract] [Full Text] [Related]
5. [New milestones in the therapy of chronic heart failure with beta blockers].
Garlichs C; Daniel WG
Z Kardiol; 2000 Mar; 89(3):236-8. PubMed ID: 10798280
[No Abstract] [Full Text] [Related]
6. [Beta blockers for therapy of chronic heart failure].
Murakami T
Nihon Naika Gakkai Zasshi; 2005 Feb; 94(2):248-54. PubMed ID: 15768588
[No Abstract] [Full Text] [Related]
7. A comment on COMET: how to interpret a positive trial?
Massie BM
J Card Fail; 2003 Dec; 9(6):425-8. PubMed ID: 14966781
[No Abstract] [Full Text] [Related]
8. Prognostic Benefits of Carvedilol, Bisoprolol, and Metoprolol Controlled Release/Extended Release in Hemodialysis Patients with Heart Failure: A 10-Year Cohort.
Tang CH; Wang CC; Chen TH; Hong CY; Sue YM
J Am Heart Assoc; 2016 Jan; 5(1):. PubMed ID: 26738790
[TBL] [Abstract][Full Text] [Related]
9. Do beta-blockers prolong survival in heart failure only by inhibiting the beta1-receptor? A perspective on the results of the COMET trial.
Packer M
J Card Fail; 2003 Dec; 9(6):429-43. PubMed ID: 14966782
[TBL] [Abstract][Full Text] [Related]
10. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality.
Perreault S; de Denus S; White M; White-Guay B; Bouvier M; Dorais M; Dubé MP; Rouleau JL; Tardif JC; Jenna S; Haibe-Kains B; Leduc R; Deblois D
Pharmacoepidemiol Drug Saf; 2017 Jan; 26(1):81-90. PubMed ID: 27859924
[TBL] [Abstract][Full Text] [Related]
11. Which beta-blocker for heart failure?
Patel MR; Gattis W
Am Heart J; 2004 Feb; 147(2):238. PubMed ID: 14760319
[No Abstract] [Full Text] [Related]
12. Carvedilol in the treatment of chronic heart failure: lessons from the Carvedilol Or Metoprolol European Trial.
Kveiborg B; Major-Petersen A; Christiansen B; Torp-Pedersen C
Vasc Health Risk Manag; 2007; 3(1):31-7. PubMed ID: 17583173
[TBL] [Abstract][Full Text] [Related]
13. [The COMET study compares effect of two different beta-blockers in chronic heart failure. Carvedilol better than metoprolol].
Swedberg K
Lakartidningen; 2003 Sep; 100(37):2852-4. PubMed ID: 14558169
[No Abstract] [Full Text] [Related]
14. beta-adrenergic receptor blockade in chronic heart failure.
Bristow MR
Circulation; 2000 Feb; 101(5):558-69. PubMed ID: 10662755
[No Abstract] [Full Text] [Related]
15. Current research on carvedilol in heart failure.
Bobadilla RV
Crit Care Nurse; 2002 Aug; 22(4):14, 16. PubMed ID: 12166050
[No Abstract] [Full Text] [Related]
16. Major beta blocker mortality trials in chronic heart failure: a critical review.
McMurray JJ
Heart; 1999 Dec; 82 Suppl 4(Suppl 4):IV14-22. PubMed ID: 10574906
[No Abstract] [Full Text] [Related]
17. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
Poole-Wilson PA
Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
[TBL] [Abstract][Full Text] [Related]
18. The impact of beta-blockade on mortality rates in patients with congestive heart failure.
Goldstein S; Gottlieb SS
J Card Fail; 2000 Jun; 6(2 Suppl 1):15-24. PubMed ID: 10908094
[TBL] [Abstract][Full Text] [Related]
19. [Congestive heart failure in Spain: cost-effectiveness and cost-benefit analyses of treatment with beta-blockers].
Díez Manglano J
Rev Clin Esp; 2005 Apr; 205(4):149-56. PubMed ID: 15860185
[TBL] [Abstract][Full Text] [Related]
20. Carvedilol and metoprolol European trial: do the results merit challenge?
Smith KM
Am J Health Syst Pharm; 2004 Jun; 61(12):1289-93. PubMed ID: 15259762
[No Abstract] [Full Text] [Related]
[Next] [New Search]
